We're thrilled to announce that Quantumcyte has selected Scispot.io (YC S21) as its preferred digital partner to digitalize and automate its workflows.

QuantumCyte uses Scispot to standardize its molecular pathology workflows, manage and track its samples and inventory, automate repetitive tasks and maintain a full audit trail. Scispot combines the functionalities of LIMS (lab information management system) and ELN (electronic lab notebook) into one platform.  Scispot’s intuitive and user-friendly interface supports operational workflow automation of equipment maintenance, inventory consumption, report creation, and much more.

“QuantumCyte is growing globally, and Scispot will help accelerate our growth and expand our digital footprint. Scispot consolidates our company-wide operations and enhances the quality and efficiency of our science,” says John Butler, Founder & CEO of QuantumCyte. 

‍

“QuantumCyte matched the profile of our ideal customer: a modern, fast-growing life science company that is ready to expand its digital presence, states Guru Singh, Founder & CEO of Scispot

‍

Scispot has become the digital operating platform of choice for many innovative biotech and diagnostics startups since its official launch in Q2 2021. QuantumCyte joining our customer base further strengthens our position as a market leader in the biostartup segment.

‍

Read the press release here.

‍